- UID
- 69
- 閱讀權限
- 35
- 精華
- 0
- 威望
- 3
- 貢獻
- 1086
- 活力
- 19
- 金幣
- 2199
- 日誌
- 0
- 記錄
- 0
- 最後登入
- 2016-2-3
 
- 文章
- 672
- 在線時間
- 314 小時
|
本文章最後由 frank 於 2010-10-12 10:16 編輯
# V' e& X& R' Z* [+ {& }% h
5 m* J8 Y. {5 F( S' [關於窄頻雷射治療鼻子過敏,我個人感覺還滿有效的,建議大家可以試試看,當然,也有人完全沒效,不過,有沒有效,試了才知道,而且沒有什麼副作用,而且又免費,嘿嘿! 建議大家可以試試看! ' }8 i6 |5 J) X7 ^% O
對了,若是因為鼻息肉或鼻竇炎所引發的鼻塞或鼻子不適,還是要先將這些問題處理完,再做這雷射治療,因為以目前我看到的文獻,並沒有以此類方式治療鼻息肉或鼻竇炎的文獻,引用一份文獻和各位分享 : 5 u: v0 Q% J- J( W% [
原始期刊報告:Neuman I, Finkelstein Y. Narrow-band red light phototherapy in perennial allergic rhinitis and nasal polyposis. Annals of Allergy, Asthma & Immunology. 1997, 78: 399–406. 窄頻紅光光線療法對治療慢性過敏性鼻炎及鼻息肉症的效果,過敏、氣喘及免疫學期刊(美國)。7 K( r$ V) _( e( P r
; V. [ P, W7 C- r: v9 Z1 d. m過敏性鼻炎是所有免疫球蛋白E-中介性過敏反應中最常見之疾病,有高達30﹪的兒童及成人深受其害。患者一般接受包括抗組織胺、減充血劑、局部或全身類固醇、噴鼻液、鼻噴劑、異丙托溴銨或減敏治療等治療,儘管被普遍採用,但面對可能產生的併發症或後遺症,治療上還是不太理想。3 A2 K* Y+ W, _& S7 |
7 g# x8 Y2 r/ w, W6 v
低能量窄頻紅光光線療法已經成功運用在許多醫學治療領域中,其中660 nm的紅光照射已被證實能抑制血液中活性氧生成,並影響Ca2+的移轉。由於過敏症狀有相當大的部分起因於活性氧的生成與Ca2+的移轉,因此嘗試用660 nm紅光治療過敏性鼻炎症狀患者。
- T5 M# j( |" G; g . `! H+ p$ q2 J) X6 L
研究共收納實驗組(使用660nm紅光照射)50位、對照組(假光照射)29位的慢性過敏性鼻炎患者,部分患者合併有支氣管性氣喘。過敏性鼻炎以鼻癢、流鼻水、打噴嚏、鼻塞以及相關症狀作為判斷,每位病患並接受皮膚戳刺檢查確認過敏反應。罹患鼻竇炎及鼻竇異常者則不納入。
; P% {) A% a" _6 X
/ i8 P4 o5 q' A& w& F6 U5 x本研究採雙盲、隨機與平行試驗的方式進行,每位患者接受660nm紅光或假光照射治療,每天3次、每次4.4分鐘(光能量1焦耳)共14天。在光療期間病患不得服用其他藥物,治療結果依病患主觀改善程度及醫師鼻內視鏡檢查結果作為評斷。0 i# w9 a% R: ]
& o Y0 ` I r
結果顯示,以660nm紅光照射治療後,有80﹪患者的鼻塞症狀、81﹪患者的流鼻水狀況獲得改善。由鼻內視鏡檢查則發現,61%的鼻塞狀況、65﹪的流鼻水症狀以及48%的中鼻甲水腫症狀獲得改善;至於鼻搔癢、及咳嗽(鼻後滴漏)症狀的病患主觀感受到改善的比例分別為60﹪、70﹪及69﹪。
. I+ G- u+ J! y1 Z( h6 m. H
1 i# q, O9 B/ T( ^" b而照射假光的過敏性鼻炎患者,在鼻塞、流鼻水、鼻搔癢、頭痛及咳嗽症狀上的病患主觀改善率分別為31%、14%、32%、20%及21%。鼻內視鏡檢查在鼻塞、流鼻水、中鼻甲水腫的改善率則為21%、7%及12%。3 @3 `. b1 x& {: H, @
3 d) m" n8 z% d+ J總和評估以660nm紅光治療過敏性鼻炎症狀,在主觀感受上有72%的病患認為有效,在鼻內視鏡檢查中顯現對70%的病患有效;在假光組則為24%及21%。
4 d/ p" A6 r+ B% _; a+ y
" r5 U) S& f' n! Y3 {' \+ o2 B3 b◎660nm紅光對改善過敏性鼻炎症狀的治療效果(n=50)
3 P' Z9 J# Y7 k$ [$ M; k( p% x5 c$ j6 d" A4 v5 v! \
原始文獻:
/ |6 n: ?3 F' y- ^' p$ oBACKGROUND: Allergic rhinitis and nasal polyposis are common nasal diseases, but the available treatment modalities have only limited success. OBJECTIVE: To assess the therapeutic effect of low-energy narrow-band red light phototherapy on nasal clinical symptoms of allergic rhinitis and nasal polyposis. METHODS: In a double-blind randomized prospective study, 50 patients with allergic rhinitis and 10 with nasal polyposis received intranasal illumination at 660 nm for 4.4 minutes three times a day for 14 days (total dose 6 joules per day). Twenty-nine rhinitic patients and one patient with polyposis received equivalent sham illumination as placebo. Evaluation was based on symptom scores and a clinical assessment that included pre-treatment and post-treatment videotaped rigid and flexible nasendoscopy. RESULTS: Following treatment, improvement of symptoms was reported by 72% of the allergic rhinitis patients and objective improvement was endoscopically demonstrated in 70% of them as compared with 24% and 3%, respectively, in the placebo group. These differences were significant. No improvement was obtained in any of the patients with polyposis. CONCLUSIONS: Allergic rhinitis, if uncomplicated by polyps or chronic sinusitis, can be effectively treated by narrow-band red light illumination of the nasal mucosa at 660 nm, with marked alleviation of clinical symptoms. Whenever possible, candidates for phototherapy should be selected by endoscopic examination.
9 R; Y c* p$ \' t
. N% f! O k" o; A& z中文部分原始出處 |
|